Parallel Imports – Lorna Welbourn

by | Mar 5, 2019 | Blog

The UK Parallel Importing scheme allows for a medicinal product authorised in another EU member state to be marketed in the UK providing there is no therapeutic difference.  In order to parallel import (PI) and repackage medicinal products, relevant licences would be needed.

 

Parallel Importing medicinal products can be a daunting prospect, with so many different aspects bought together to ensure a safe and reliable licence – from accurate leaflets and labelling to Trademark approval. Understanding the complexities and getting it right first time can be crucial to your business.

 

Understandably, Brexit is creating an uncertain time for all industries especially those which rely so heavily on relations with the EU – however you can rest-assured that regardless of the outcome, Parallel Imports of pharmaceuticals will continue.

 

Most medicinal products, diagnostics and non-licenced products can be imported but there are different rules and regulations that will need to be followed depending on what is being imported.  For example importing non-licenced products can be a quick, exciting and diverse route to expand to with the right expertise, and for Prescription Only Medicines (POM) you will need to ensure that you comply with the Falsified Medicines Directive (FMD).

 

Parallel Importing has been one of the biggest driving forces for the industry to reduce drug costs, therefore there will always be a need and desire for PIs.

 

Lorna has over 15 years of experience in Parallel Importing, and works with you to deliver your business targets.

 

Whether you’re embarking on PI for the first time, or you are already established and need additional support, Lorna and her team will provide a safe, flexible and professional service. Agreements are bespoke – tailored to your individual needs.

 

Contact us now to see how we can work with you to help you achieve your goals at [email protected]

Testimonials

Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training